PDF herunterladen
Thorac Cardiovasc Surg 2011; 59(7): 421-424
DOI: 10.1055/s-0030-1270835
Original Cardiovascular

© Georg Thieme Verlag KG Stuttgart · New York

Aspirin Does Not Increase Bleeding and Allogeneic Blood Transfusion in Coronary Artery Surgery

E. Hijazi1
  • 1Division of Cardiac Surgery, Department of General Surgery, Princess Muna Al-Hussein Cardiac Center, King Abdullah University Hospital – Faculty of Medicine/Jordan University of Science and Technology, Irbid, Jordan
Weitere Informationen

Publikationsverlauf

received June 22, 2010 resubmitted Dec. 14, 2010

accepted January 10, 2011

Publikationsdatum:
20. April 2011 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Erratum zu diesem Artikel:

Erratum to: Aspirin does not increase bleeding and allogenic blood transfusion in coronary artery surgery. Thorac Cardiovasc Surg 2011;59:421-424Thorac Cardiovasc Surg 2013; 61(03): 270-270
DOI: 10.1055/s-0033-1343495

Abstract

Background: Traditionally, the administration of aspirin is stopped seven days before coronary artery bypass surgery to reduce the risk of postoperative bleeding. The aim of this study was to evaluate the effect of preoperative aspirin on bleeding in these patients. Methods: A prospective nonrandomized unblinded study was carried out at the King Abdullah University Hospital in Jordan/Irbid from June 2005 to December 2009 in 756 patients. Patients were divided into 2 groups: Group 1 (n = 400) consisted of patients on aspirin, 100 mg/day, until the day of surgery; Group 2 (n = 356) consisted of patients who stopped taking aspirin seven days before surgery. The groups were compared to evaluate the effect of preoperative aspirin on bleeding in patients undergoing elective coronary artery bypass surgery. Data were collected and compared and included total amount of postoperative chest tube drainage, number of transfused units of blood and blood products, and numbers of patients who required reexploration for bleeding. Results were considered significant when p < 0.05. Results: There was no significant increase in the amount of blood loss, units of transfused blood products, or the incidence of reexploration between the two groups (p > 0.05). Conclusion: Aspirin does not increase bleeding or increase the need for allogeneic blood transfusion in coronary artery surgery.

Key words

coronary bypass surgery - cardiovascular surgery - heart disease

References

  • 1 Sethi G K, Copeland J G, Goldman S, Moritz T, Zadina K, Henderson W G. Should aspirin be discontinued before coronary artery bypass surgery?.  Circulation. 2005;  112 e85-e90
    CrossrefPubMedSuche in Google Scholar
  • 2 Eagle K A, Guyton R A, Davidoff R. et al. for the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery . ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.  J Am Coll Cardiol. 2004;  44 e213-310
    CrossrefPubMedSuche in Google Scholar
  • 3 Stein P D, Schunemann H J, Dalen J E, Gutterman D. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126 (Suppl. 3) 600S-608S
    CrossrefPubMedSuche in Google Scholar
  • 4 Antiplatelet Trialists' Collaboration . Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.  BMJ. 2002;  324 71-86
    CrossrefPubMedSuche in Google Scholar
  • 5 Hayat J, Dihmis W C. Preoperative and immediate postoperative aspirin also reduces morbidity.  Ann Thorac Surg. 2001;  72 1797-1798
    PubMedSuche in Google Scholar
  • 6 Goldman S, Copeland J, Moritz T and the Department of Veterans Affairs Cooperative Study Group et al. Starting aspirin therapy after operation: effects on early graft patency.  Circulation. 1991;  84 520-526
    CrossrefPubMedSuche in Google Scholar
  • 7 Goldman S, Copeland J, Moritz T et al. Improvement in saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.  Circulation. 1988;  77 1324-1332
    CrossrefPubMedSuche in Google Scholar
  • 8 Hockings B E F, Ireland M A, Gotch-Martin K F, Taylor R R. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients.  Med J Aust. 1993;  159 376-378
    PubMedSuche in Google Scholar
  • 9 Vuylsteke A, Oduro A, Cardan E, Latimer R D. Effect of aspirin in coronary artery bypass grafting.  J Cardiothorac Vasc Anesth. 1997;  11 831-834
    CrossrefPubMedSuche in Google Scholar
  • 10 Dacey L J, Munoz J J, Johnson E R Northern New England Cardiovascular Disease Study Group et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients.  Ann Thorac Surg. 2000;  70 (6) 1986-1990
    CrossrefPubMedSuche in Google Scholar
  • 11 Bybee K A, Powell B D, Valeti U et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting.  Circulation. 2005;  112 (Suppl. 1) I-286-I-292
    PubMedSuche in Google Scholar
  • 12 Ferraris V A, Ferraris S P, Lough F C, Berry W R. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting.  Ann Thorac Surg. 1988;  45 71-74
    CrossrefPubMedSuche in Google Scholar
  • 13 Sethi G K, Copeland J G, Goldman S, Moritz T, Zadina K, Henderson W G. and the Department of Veterans Affairs Cooperative Study Group . Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting.  J Am Coll Cardiol. 1990;  15 15-20
    CrossrefPubMedSuche in Google Scholar
  • 14 Kallis P, Tooze J A, Talbot S, Cowans D, Bevan D H, Treasure T. Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss: a prospective, randomized, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina.  Eur J Cardiothorac Surg. 1994;  8 404-409
    CrossrefPubMedSuche in Google Scholar
  • 15 Taggart D P, Siddiqui A, Wheatley D J. Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements.  Ann Thorac Surg. 1990;  50 425-428
    CrossrefPubMedSuche in Google Scholar
  • 16 Tuman K J, McCarthy R J, O'Connor C J, McCarthy W E, Ivankovich A D. Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery.  Anesth Analg. 1996;  83 (6) 1178-1184
    PubMedSuche in Google Scholar
  • 17 Bashein G, Nessly M L, Rice A L et al. Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery.  Arch Intern Med. 1991;  151 89-93
    CrossrefPubMedSuche in Google Scholar
  • 18 Boldt J, Knothe C, Zickmann B et al. The effects of preoperative aspirin therapy on platelet function in cardiac surgery.  Eur J Cardiothorac Surg. 1992;  6 598-602
    CrossrefPubMedSuche in Google Scholar
  • 19 Torosian M, Michelson E L, Morganroth J, MacVaugh H. Aspirin- and coumadin-related bleeding after coronary-artery bypass graft surgery.  Ann Intern Med. 1978;  89 525-528
    PubMedSuche in Google Scholar
  • 20 Troianos C A, Mathie T B, Galaska H J et al. Perioperative factors associated with homologous blood transfusions and cardiac surgery [abstract].  Anesth Analg. 1996;  82 SCA104
    PubMedSuche in Google Scholar
  • 21 Despotis G J, Filos K S, Zoys T N, Spitznagel E, Lappas D G. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients.  Anesth Analg. 1996;  82 13-21
    PubMedSuche in Google Scholar
  • 22 Paone G, Spencer T, Silverman N A. Blood conservation in coronary artery surgery.  Surgery. 1994;  116 672-678
    PubMedSuche in Google Scholar
  • 23 Reich D L, Patel G C, Vela-Cantos F, Bodian C, Lansman S. Aspirin does not increase homologous blood requirements in elective coronary bypass surgery.  Anesth Analg. 1994;  79 4-8
    PubMedSuche in Google Scholar
  • 24 Rawitscher R E, Jones J W, McCoy T A, Lindsley D A. A prospective study of aspirin's effect on red blood cell loss in cardiac surgery.  J Cardiovasc Surg. 1991;  32 1-7
    PubMedSuche in Google Scholar
  • 25 Ferraris V A, Gildengorin V. Predictors of excessive blood use after coronary artery bypass grafting.  J Thorac Cardiovasc Surg. 1989;  98 492-497
    PubMedSuche in Google Scholar
  • 26 Giordano Sr G F, Giordano Jr G F, Rivers S L et al. Determinants of homologous blood usage utilizing autologous platelet-rich plasma in cardiac operations.  Ann Thorac Surg. 1989;  47 897-902
    CrossrefPubMedSuche in Google Scholar
  • 27 Kamran M, Ahmed A, Dar M I, Khan A B. Effect of aspirin on postoperative bleeding in coronary artery bypass grafting.  Ann Thorac Cardiovasc Surg. 2008;  14 (4) 224-229
    PubMedSuche in Google Scholar
  • 28 Mangano D T. Multicenter study of perioperative ischemia research group. Aspirin and mortality from coronary artery bypass surgery.  N Engl J Med. 2002;  347 1309-1317
    CrossrefPubMedSuche in Google Scholar
  • 29 Chesebro J H, Clements I P, Fuster V et al. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.  N Engl J Med. 1982;  307 (2) 73-78
    CrossrefPubMedSuche in Google Scholar

Dr. Emad Hijazi

Department of General Surgery
King Abdullah University Hospital – Faculty of Medicine/Jordan University of Science and Technology

Irbid 22110

Jordan

Telefon: +962 7 96 30 10 96

Fax: +962 27 10 27 99

eMail: emad_hijazi@hotmail.com